132 related articles for article (PubMed ID: 12507784)
1. Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis.
Sharief MK; Matthews H; Noori MA
J Neuroimmunol; 2003 Jan; 134(1-2):158-65. PubMed ID: 12507784
[TBL] [Abstract][Full Text] [Related]
2. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis.
Sharief MK; Douglas M; Noori M; Semra YK
J Neuroimmunol; 2002 Apr; 125(1-2):155-62. PubMed ID: 11960652
[TBL] [Abstract][Full Text] [Related]
3. Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis.
Sharief MK; Noori MA; Douglas MR; Semra YK
Eur J Neurol; 2002 Sep; 9(5):503-10. PubMed ID: 12220382
[TBL] [Abstract][Full Text] [Related]
4. The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis.
Seidi OA; Sharief MK
J Neuroimmunol; 2002 Sep; 130(1-2):202-10. PubMed ID: 12225903
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of the inhibitor of apoptosis proteins in T cells from patients with multiple sclerosis following interferon-beta therapy.
Sharief MK; Noori MA; Zoukos Y
J Neuroimmunol; 2002 Aug; 129(1-2):224-31. PubMed ID: 12161039
[TBL] [Abstract][Full Text] [Related]
6. Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins.
Semra YK; Seidi OA; Sharief MK
J Neuroimmunol; 2002 Jan; 122(1-2):159-66. PubMed ID: 11777555
[TBL] [Abstract][Full Text] [Related]
7. Elevated Bcl-X(L) levels correlate with T cell survival in multiple sclerosis.
Waiczies S; Weber A; Lünemann JD; Aktas O; Zschenderlein R; Zipp F
J Neuroimmunol; 2002 May; 126(1-2):213-20. PubMed ID: 12020973
[TBL] [Abstract][Full Text] [Related]
8. Quantification of Bax/Bcl-2 ratios in peripheral blood lymphocytes, monocytes and granulocytes and their relation to susceptibility to anti-Fas (anti-CD95)-induced apoptosis.
Van Der Vliet HJ; Wever PC; Van Diepen FN; Yong SL; Ten Berge IJ
Clin Exp Immunol; 1997 Nov; 110(2):324-8. PubMed ID: 9367420
[TBL] [Abstract][Full Text] [Related]
9. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
10. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis.
Sharief MK
J Neuroimmunol; 2000 Sep; 109(2):236-43. PubMed ID: 10996226
[TBL] [Abstract][Full Text] [Related]
11. Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RS.
Di Renzo M; Serrano D; Zhou Z; George I; Becker K; Cunningham-Rundles C
Clin Exp Immunol; 2001 Jul; 125(1):117-22. PubMed ID: 11472434
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the inhibitor of apoptosis proteins in activated T lymphocytes from patients with multiple sclerosis.
Sharief MK; Semra YK
J Neuroimmunol; 2001 Oct; 119(2):350-7. PubMed ID: 11585639
[TBL] [Abstract][Full Text] [Related]
13. Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis.
Julià E; Montalban X; Al-Zayat H; Issazadeh-Navikas S; Goertsches R; Martin R; Comabella M
J Neuroimmunol; 2006 Nov; 180(1-2):147-58. PubMed ID: 16899302
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis.
Sharief MK; Semra YK
Arch Neurol; 2002 Jul; 59(7):1115-21. PubMed ID: 12117359
[TBL] [Abstract][Full Text] [Related]
15. Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis.
Sharief MK; Semra YK; Seidi OA; Zoukos Y
J Neuroimmunol; 2001 Nov; 120(1-2):199-207. PubMed ID: 11694335
[TBL] [Abstract][Full Text] [Related]
16. Investigation of bax, bcl-2, bcl-x and p53 gene polymorphisms in multiple sclerosis.
Kuhlmann T; Glas M; zum Bruch C; Mueller W; Weber A; Zipp F; Brück W
J Neuroimmunol; 2002 Aug; 129(1-2):154-60. PubMed ID: 12161031
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis.
Semra YK; Seidi OA; Sharief MK
J Neuroimmunol; 2001 Feb; 113(2):268-74. PubMed ID: 11164911
[TBL] [Abstract][Full Text] [Related]
18. Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.
Ruggieri M; Avolio C; Scacco S; Pica C; Lia A; Zimatore GB; Papa S; Livrea P; Trojano M
J Neurol; 2006 Feb; 253(2):231-6. PubMed ID: 16184340
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions.
Zettl UK; Kuhlmann T; Brück W
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):202-8. PubMed ID: 9717185
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in association with suppression of Bax.
Goetzl EJ; Kong Y; Mei B
J Immunol; 1999 Feb; 162(4):2049-56. PubMed ID: 9973477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
